Friday - July 03, 2026

IGC Pharma (NYSE: IGC) CEO and CFO Acquire More Than 4.2 Million Shares

IGC Pharma, Inc. (NYSE: IGC), a clinical-stage biotechnology company developing Alzheimer’s disease therapeutics and AI-enabled healthcare technologies, disclosed in a Form 4 filing that two senior executives increased their ownership stakes through debt-for-equity transactions. According to the filing dated July … Continue reading

Graphene Manufacturing (TSXV: GMG) (OTCQX: GMGMF) CEO Discusses Commercial Graphene Growth and Global Expansion Watch Now!

Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) continues to build momentum as the company expands production, secures new commercial partnerships, and advances the commercialization of its graphene technology platform. Founder and CEO Craig Nicol recently appeared on CEO.CA to … Continue reading

Nanocap News: AMLM, INLF, AMFN, HYSR, DOSE Lead Multibagger Radar Stocks

As investors continue searching for undiscovered opportunities beyond the large-cap market, a new wave of nanocap companies is attracting attention across some of today’s fastest-growing sectors, including critical minerals, industrial automation, fusion energy, renewable hydrogen, biotechnology, and advanced manufacturing. While … Continue reading

Stocks Under $1: TNMG, SRFM, PRSO, KNDI, IGC Offer Multibagger Potential as AI Boom Accelerates

As investors continue searching for the next generation of multibagger opportunities, several companies trading near or under the $1 level are capturing attention through major developments across Artificial Intelligence (AI), autonomous aviation, defense technology, digital infrastructure, battery storage, and Alzheimer’s … Continue reading